Nearly 5,000 families affected by childhood cancer have received help thanks to Penn State THON, which raises money for Four ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

The initial focus of gamma delta T cell therapy development has been on cancer treatment, particularly hematologic cancers such as leukemia and acute myeloid leukemia (AML), where the therapies have ...

including T-cell lymphoma (TCL), T-cell acute lymphoblastic leukemia (T-ALL), chronic lymphocytic leukemia (CLL), and mantle cell lymphoma (MCL). The therapy employs a proprietary CAR design that ...

The team discovered a unique population of immune cells that is important to the successful treatment of relapsed acute myeloid leukemia (AML). This investigation was done in partnership with the ...

In addition, the donor cells also include active immune cells that can attack leukemia cells that remain in the patient after the transplant. This phenomenon is called the graft versus leukemia ...

If acute forms of leukemia are involved, the onset may be sudden. If chronic forms are involved, they may develop slowly and be harder to recognize. The symptoms are largely due to the onset of anemia ...

In addition, the donor cells also include active immune cells that can attack leukemia cells that remain in the patient after the transplant. This phenomenon is called the graft versus leukemia ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...